Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Chemical Communications (Cambridge, England)|December 4, 2003
Facilitation of addition-elimination reactions in pyrimidines and purines using trifluoroacetic acid in trifluoroethanolHayley J Whitfield, Roger J Griffin, Ian R Hardcastle, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2004
Identification of a highly potent and selective DNA-dependent protein kinase (DNA-PK) inhibitor (NU7441) by screening of chromenone librariesJustin J J Leahy, Bernard T Golding, Roger J Griffin, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 2010
Mapping the ATP-binding domain of DNA-dependent protein kinase (DNA-PK) with coumarin- and isocoumarin-derived inhibitorsSara L Payne, Sonsoles Rodriguez-Aristegui, Julia Bardos, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 2003
2,6-disubstituted pyran-4-one and thiopyran-4-one inhibitors of DNA-Dependent protein kinase (DNA-PK)Jonathan J Hollick, Bernard T Golding, Ian R Hardcastle, et al.
Organic & Biomolecular Chemistry|November 21, 2007
Quinolinone and pyridopyrimidinone inhibitors of DNA-dependent protein kinaseOlivier R Barbeau, Celine Cano-Soumillac, Roger J Griffin, et al.
European Journal of Cancer (Oxford, England : 1990)|May 17, 2011
Preclinical in vitro and in vivo evaluation of the potent and specific cyclin-dependent kinase 2 inhibitor NU6102 and a water soluble prodrug NU6301Huw D Thomas, Lan-Zhen Wang, Celine Roche, et al.
Organic & Biomolecular Chemistry|July 21, 2012
Potent enantioselective inhibition of DNA-dependent protein kinase (DNA-PK) by atropisomeric chromenone derivativesKate M Clapham, Tommy Rennison, Gavin Jones, et al.
Journal of the American Chemical Society|May 4, 2006
Searching for cyclin-dependent kinase inhibitors using a new variant of the cope eliminationRoger J Griffin, Andrew Henderson, Nicola J Curtin, et al.
Pageof 6